chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Diarrhea for 4 days, not able to eat more than crackers and pedialyte, no energy, very tired.  The stools there were was very dark and still continuing to have loose dark stools. Felt like I was in a fog.
I woke up 7 days after the moderna vaccine with a large rash around the injection site (right arm). It is itchy and hot, but not painful. My lymph node in my right armpit is tender. No fever. No soreness. From my own research, I noticed that this seemed to be underreported, so I wanted to do my part by reporting it. I am happy to supply pictures too if needed.
Dizziness, episode of fainting, vomiting, headache, chills, heavy sweating, muscle fatigue, tiredness
slightly elevated heart rate, 101 BPM.; Facial swelling, skin on face feels tight; Throat feels slightly swollen; lightheaded; Woke up in a sweat this morning; slight muscle aches in neck & shoulders; chills last night; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (slightly elevated heart rate, 101 BPM.), SWELLING FACE (Facial swelling, skin on face feels tight), PHARYNGEAL SWELLING (Throat feels slightly swollen), DIZZINESS (lightheaded) and HYPERHIDROSIS (Woke up in a sweat this morning) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced HEART RATE INCREASED (slightly elevated heart rate, 101 BPM.), SWELLING FACE (Facial swelling, skin on face feels tight), PHARYNGEAL SWELLING (Throat feels slightly swollen), DIZZINESS (lightheaded), HYPERHIDROSIS (Woke up in a sweat this morning), MYALGIA (slight muscle aches in neck & shoulders) and CHILLS (chills last night). At the time of the report, HEART RATE INCREASED (slightly elevated heart rate, 101 BPM.), SWELLING FACE (Facial swelling, skin on face feels tight), PHARYNGEAL SWELLING (Throat feels slightly swollen), DIZZINESS (lightheaded), HYPERHIDROSIS (Woke up in a sweat this morning), MYALGIA (slight muscle aches in neck & shoulders) and CHILLS (chills last night) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided    Reporter did not allow further contact
Patient received 3 doses of covid pfizer vaccination prior to admission.  Patient is under hospice services. 8-9-21 at 9:30pm, he expired in house
Patient desribes an itchy rash with red bumps beginning the morning of 4/10/2019. Patient's dermatologist started her on valacyclovir and an antihistamine 4/12/19. Currently adverse event is still unresolved.
Right arm muscle became tight and painful to move. Patient could not lift arm more than a few inches. Have encouraged gentle stretching and movement. Took one dose of Naproxen. Lingering issue of tightness remains.
Started 3:00pm Saturday 3/20/21.  Shortness of breath after two days taking vaccine - rest and vapor rub
Immunization: COVID-19 PF (Janssen/J&J), External Administration - vaccine was administered outside of the clinic- reported by patient   ACUTE RESPIRATORY FAILURE 12/20/2021 MOUTH CANCER, UNSPECIFIED SITE  ACUTE RESPIRATORY FAILURE 12/20/2021 SQUAMOUS CELL CARCINOMA, MOUTH, UNSPECIFIED SITE  ACUTE RESPIRATORY FAILURE 12/20/2021 CANCER METASTATIC TO UNSPECIFIED LN
Patient stated he started having hives, diarrhea and chills 2 days after the vaccine. At the current time, 2 weeks later, he is still having the same adverse events and now has leg weakness.
This study case was received from the investigator in a trial on 11 March 2013. A male subject (date of birth not reported) had received the following vaccinations on 28 February 2013: ACAM2000 (lot number, route and site not reported), typhoid (Manufacturer Unknown, lot number, route and site not reported), and anthrax (Other Manufacturer, lot number, route and site not reported). Eight days later, the subject was found to have an elevated Troponin level (adverse event start date reported as 08 March 2013). The troponin lab values were drawn on 07 March 2013 with an elevated value of 0.28 ng/ml. Labs were drawn for re-evaluation but not reported. On 11 March 2013, the subject had an ECG with pending interpretation and referred to medical. The subject reported no chest pain and no cardiac symptoms. No further information was available at the time of the report. The subject's outcome was not recovered. According to the Investigator, the event of elevated troponin was considered an important event and possibly related. Per the Investigator, this represents a case of potential myopericarditis and was referred to the ACAM2000 Myopericarditis Adjudication Committee for assessment. Documents held by sender: None.
Patient developed redness, swelling, warmth, pain, and itchiness at the site of injection (right deltoid) of TDaP and MENACTRA vaccines and symptoms started two days ago 11/20/17.
This spontaneous report was received from a nurse practitioner referring to a 13 year old female patient. In an unknown date in 2013, the patient received one dose of GARDASIL (dose, frequency, route of administration and indication were not reported). However, the second dose administered, in approximately December 2015 (reported as 2 months ago) was GARDASIL 9 (dose, frequency, route of administration and indication were not reported). No adverse effects reported. Additional information is not expected. The reporter did not wish to be contacted.
Day 1: The morning after my second Moderna dose, the area surrounding the injection site was red, warm to the touch, inflamed and hard, and very, very sore when touched. Day 2:  All symptoms were the same, although the inflamation appeared slightly less Day 3: All symptoms although still present, were much less noticeable Day 4: All symptoms gone
5/16/2020 awake c/o body aches, chills + fever, temp @ 101.0 + headache. Took one Tylenol. 5/18/2020 Better today with slight (L) deltoid soreness.
headache; high fever/highest registered fever was 102 degrees.; fatigue; Ill for 2 1/2 days; Self treated with ibuprofen and tylenol for fever and sleep; red big blotch about 4 inches tall and 6 iches wide on arm; Itching; This spontaneous case was reported by a patient and describes the occurrence of HEADACHE (headache), PYREXIA (high fever/highest registered fever was 102 degrees.), FATIGUE (fatigue), ILLNESS (Ill for 2 1/2 days) and SLEEP DISORDER (Self treated with ibuprofen and tylenol for fever and sleep) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: INFLUENZA VACCINE (Always wind up with case of flu after receiving shot.). Concurrent medical conditions included Hay fever. Concomitant products included VITAMIN D2 for Deficiency vitamin, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE (NEXIUM [ESOMEPRAZOLE MAGNESIUM TRIHYDRATE]) for GERD, LEVOTHYROXINE SODIUM (LEVOTHYROXIN) for Hypothyroidism, HYDROCHLOROTHIAZIDE, IRBESARTAN (IRBESARTAN HCTZ) and LIOTHYRONINE for an unknown indication.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache), PYREXIA (high fever/highest registered fever was 102 degrees.), FATIGUE (fatigue), ILLNESS (Ill for 2 1/2 days), SLEEP DISORDER (Self treated with ibuprofen and tylenol for fever and sleep), RASH MACULAR (red big blotch about 4 inches tall and 6 iches wide on arm) and PRURITUS (Itching). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Redness, at an unspecified dose and frequency; GRAMICIDIN, POLYMYXIN B SULFATE (POLYSPORIN [GRAMICIDIN;POLYMYXIN B SULFATE]) for Swelling, at an unspecified dose and frequency; IBUPROFEN for Headache, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, HEADACHE (headache), PYREXIA (high fever/highest registered fever was 102 degrees.), FATIGUE (fatigue), ILLNESS (Ill for 2 1/2 days), SLEEP DISORDER (Self treated with ibuprofen and tylenol for fever and sleep), RASH MACULAR (red big blotch about 4 inches tall and 6 iches wide on arm) and PRURITUS (Itching) outcome was unknown.
Sore arm, tingling in left arm. (Reported on 11/19/2012).
On an unspecified date, the vaccinee received an injection of Engerix-B. An unspecified time, post immunization, the vaccinee experienced constipation. Treatment and outcome were not provided. The reporter wished to remain anonymous. Therefore, no additional information will be available.
This case was reported by a other health professional and described the occurrence of thumb twitching in a 18-year-old female patient who received FLUARIX (batch number LM55C, expiry date 23rd June 2015). On 8th October 2014, the patient received FLUARIX .5 ml. On 8th October 2014, 10 min after receiving FLUARIX, the patient experienced thumb twitching. On an unknown date, the outcome of the thumb twitching was not recovered/not resolved. The reporter considered the thumb twitching to be possibly related to FLUARIX. Additional information: The pharmacist reported that a patient received Flu vaccine 10-15 minutes ago. The patient's thumb on her opposite arm (of where she received the vaccine) started to twitch almost immediately after receiving the vaccine. It only twitches when the patient is in a relaxed position, otherwise if she used the thumb, it did not twitch.
heart VTAC leading to VFIB with subsequent ICD heart shock to bring rythem back
Vaccine given beyond 30 days of refrigeration period; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given beyond 30 days of refrigeration period) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given beyond 30 days of refrigeration period). On 06-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine given beyond 30 days of refrigeration period) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered EXPIRED PRODUCT ADMINISTERED (Vaccine given beyond 30 days of refrigeration period) to be not related.    The patient received the vaccine at deltoid.  No concomitant medication was provided.  No treatment medication was provided.   This case was linked to MOD-2021-313106 (Patient Link).
CHILD DOB WRITTEN AS AND AGE WRITTEN AS 12 ON CONSENT FILLED OUT BY INDIVIDUAL IDENTIFYING AS GRANDFATHER. CHILD IDENTIFIED IN   WITH DOB .  CHILD TOO YOUNG TO RECEIVE VACCINE IN 6/2021.
post herpetic neuralgia; Dose 1 on 24Jan2021; Dose 2 on 22Aug2021 (Beyond 19-42 days); This is a spontaneous report received from contactable reporter(s) (Pharmacist and Physician).  A 78 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administration date 22Aug2021 (Lot number: 014M20A) at the age of 78 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Seropositive rheumatoid arthritis", start date: 08Aug2014 (ongoing). Concomitant medication(s) included: XELJANZ XR taken for rheumatoid arthritis (ongoing); METHOTREXATE taken for rheumatoid arthritis (ongoing). Vaccination history included: Bnt162b2 (First dose. Anatomical site of injection: unknown. Route of administration: intramuscular. Batch/Lot number: 032L20A., Patient received first covid vaccine 24jan2021. Reported she had been diagnosed with shingles by another provider 26Jan2021.), administration date: 14Jan2021, when the patient was 78 years old, for Covid-19 Immunisation, reaction(s): "Shingles"; Shingrix vaccine (Note patient received shingrix vaccine Nov2018 to Mar2019.), administration date: Nov2018, for Shingles.  The following information was reported: POST HERPETIC NEURALGIA (non-serious), outcome "unknown", described as "post herpetic neuralgia"; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious), outcome "unknown", described as "Dose 1 on 24Jan2021; Dose 2 on 22Aug2021 (Beyond 19-42 days)".  Follow-up attempts are completed. No further information is expected.
Patient developed serious reaction 2 days after getting pneumonia vaccine. She woke up 2 days later with swollen left arm. Her upper arm was dark brown and then turned red. The upper arm felt warm to the touch and developed blisters that started to puss. Symptoms started to resolve several days later. On 9/14, swelling and blisters were gone, but slight redness remained. Patient was seen by provider on 9/14 and is being follwed up by wound care. Patient received flu shot in right arm, but no issues with that vaccine.
pt recv vax 31AUG95 & 10JUL96 pt exp chickenpox w/approx 50 lesions, a fever x 3 days, malaise, anorexia;it was reported that the pt required a visit to the MD office or the ER:pt recovered from chicken pox;
Day 2 - Joint stiffness and pain in both hands, wrists, shoulders, knees and ankles.  Tightness in calf muscles and fore arms.  Unable to make a tight fist or close hand completely.  Limited movement in wrists and pain while lifting arms above parallel to the floor.  Tightness and stiffness in neck.
pt recv vax 23NOV98 & on 25NOV98 pt devel cellulitis @ inj site;it was reported that rt arm was red & swollen;pt was hosp;the reporter expressed a concern w/the specific lot of the vax;
At about 1 A.M., nine hours after my vaccine, I woke up vomiting. I continued to vomit violently for about 10 hour. The vomiting continued intermittently for 2-3 more hours. I also had a severe headache and a mild fever. I continued to feel fatigued for three days.
Sore arm; Knee replacement surgery; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and KNEE ARTHROPLASTY (Knee replacement surgery) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 36A21A) for COVID-19 vaccination.     Concurrent medical conditions included Knee deformity. Concomitant products included OXYCODONE and PARACETAMOL (TYLENOL) for Pain.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and KNEE ARTHROPLASTY (Knee replacement surgery). At the time of the report, PAIN IN EXTREMITY (Sore arm) and KNEE ARTHROPLASTY (Knee replacement surgery) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Patient has a large (golf ball sized) welt on back side of left arm that she noticed a few days after vaccine. She had a friend circle the welt and as of today (2/6/21) it has not grown. It is not red, not painful to touch, but firm. I am not sure that it is from the vaccine since it is closer to the back side of the arm and not in the deltoid muscle, though it did occur around the same time. Patient notified her doctor and was advised to ice the lump which provided no help. I advised her to actually be seen by her doctor to have it assessed. She will call to schedule an appointment.
Signs and symptoms of anaphylaxis including tingling in mouth, trouble speaking, shortness of breath, and panic. Symptoms occurred 10min after injection and lasted about 5 minutes before administering emergency EpiPen and Diphenhydramine. Patient was escorted to hospital by ambulance.
Excessive crying for four hours or more. Approximately 3-4 hours within the administration of DTaP.
Sore arm, fever of 101.00 that did not break for 24hrs, back pain, head ache, severe chills, sweating.  I took Tylenol but it did not help with any of the symptoms. My fever broke on it?s own after 24hrs
This solicited report was received from a consumer and refers to her daughter, a female patient of unknown age. The patient was enrolled in a Market Research. There was no information about the patient's concurrent conditions, medical history or concomitant medication. On an unknown date, the patient was vaccinated with a dose of M-M-R II for prophylaxis (dose, route of administration, lot number and expiration date were not reported). Shortly after receiving the vaccine, on an unspecified date, the patient experienced immune thrombocytopenic purpura (I.T.P.). Shortly after, the patient was in hospital with "no platelets" (platelet count decreased). Laboratory exams for the plague ("peste") virus came back negative. The patient had a low platelet count for 6 months. The outcome of the events immune thrombocytopenic purpura was unknown. The reporter did not assess the causality between the events and therapy with M-M-R II. Upon internal review, the event  immune thrombocytopenic purpura (I.T.P.) was determined to be medically significant. This is one of two reports received from the same reporter. Additional information has been requested. Company Causality Assessment: Based on the limited information currently available for this case, a reasonable possibility to suggest a relationship between the therapy and the reported event cannot be established. More information is requested. Company Comment- No changes to the product safety information are warranted at this time.  Merck and Co., Inc., known as MSD outside of the country, continues to monitor the safety profile of the product. Sender's Comments: US-009507513-1702USA006192.
This case was reported by a nurse via call center representative and described the occurrence of shingles an unspecified number adult patients who received SHINGRIX for prophylaxis. On an unknown date, the patients received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patients experienced shingles and general body pain. On an unknown date, the outcome of the shingles and general body pain were unknown. It was unknown if the reporter considered the shingles and general body pain to be related to SHINGRIX. Additional details were provided as follows: The case was reported by the retired nurse. The age at vaccination was not applicable. The age group adult was not reported but was captured as adult as per vaccine indication. During a discussion about dosing of SHINGRIX, the reporter stated that, some of her friends have come down with shingles after receiving 1st dose of SHINGRIX. The reporter also stated that, some patients experienced body aches. The reporter did not provide any specifics about each patient.
This spontaneous report as received from a registered nurse refers to a 9 weeks old patient. The patient's concurrent conditions, medical history and drug allergies were not reported. On 17-NOV-2016, the patient was vaccinated with an improperly stored dose of ROTATEQ, oral, (dose not reported) from lot # M014544 with expiry date: 27-NOV-2017 for prophylaxis. Concomitant medications were not reported. The vaccine was exposed to a temperature of 34.5 Fahrenheit for 100 minutes. Data logger was involved. There were no previous excursions. No adverse events were reported. Product quality complaint was not involved. This is one of the several reports received from the same reporter. Additional information is not expected as all follow up information has been received.; Sender's Comments: US-009507513-1610USA008140: US-009507513-1610USA014705:
Initial report received from healthcare professional on 04 March 2014. A '02-month-old male patient', whose medical history and concomitant medication were not reported, had received a intramuscular dose of DAPTACEL in to the left thigh (Lot number C4508AA, expiration date was not provided), Intramuscular dose of ACTHIB in to the left thigh (Lot UH829AA, expiration date was not provided), a dose of IPOL (Lot number, expiration date, route of vaccination was not provided) in to the right thigh, PREVNAR (Lot number, expiration date, route, and site of vaccination was not provided) on 17 January 2014. It was reported that post vaccination of DAPTACEL and ACTHIB patient experienced swelling of left leg from thigh to ankle and large area of redness around left thigh injection site and swelling of left leg from thigh to ankle i.e. on 17 January 2014. The details of laboratory investigation were not provided. The subject had received corrective treatment of cold compress. The event was resolved on an unspecified day. The patient was recovered from adverse event at the time of report. List of documents held by sender: none.
Fever, nausea, diarrhea, migraines, sore throat, knee swelling, scaling of skin, chest pain, severe hypertension
A pharmacist reported that a 7 year old male experienced pneumonia, fever and cough one day after receiving FluMist on Oct 21 2005. On Oct 22 2005, the patient developed a fever of 100 degrees F. On Oct 23 2005, he was brought to an urgent care center where he was prescribed oral Ceftin (Cefuroxime). On Oct 24 2005, the high grade fever persisted (temperature unrecalled) and the patient started to cough. On Oct 27 2005, a chest x ray showed pneumonia on the right upper lobe. He was seen at the doctors office, where he was given one dose of Rocephin (Ceftriaxone) via intramuscular injection. He was then sent home with prescription of oral Augmentin (co amoxiclav). The patient has not yet recovered from the adverse events at the time of this report. The reporter assessed the events as possibly related to FluMist. Additional information has been requested.
Fatigue, fever, headache, excruciating pain all over left side of body, nausea
FELT DOWN DUE TO HIGH FEVER; This spontaneous report received from a consumer via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced felt down due to high fever. The action taken with covid-19 vaccine was not applicable. The outcome of felt down due to high fever was not reported. This report was non-serious.
Information has been received from a company representative concerning a 16 week old female  who was vaccinated SC with a dose of varicella virus vaccine live. 8 days post vaccination the pt developed breakthrough varicella. Unspecified medical attention was sought. There was no product quality complaint involved. It was noted that the physician may not be contacted. No other information was available.
Patient was seen in office for sinus infection and allergies.  Patient was administered GARDASIL and when patient left the office, she vomited and had a syncope episode.  Mom took her to ER under direction of office.  Vomited again.
Client reported chest pain radiating to lower back. He originally reported the pain as a 10/10. EMS were phoned as nurses remained with client obtaining vitals (which all remained within normal limitis). Upon the paramedics arrival, the client was evaluated. He ultimately refused further treatment/transfer to hospital.